Skip to content

Investigation of the Efficacies of a Resveratrol Formula on Improvement of Skin Conditions and Inflammatory Related Factors

Investigation of the Efficacies of a Resveratrol Formula on Improvement of Skin

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04456829
Acronym
Resveratrol
Enrollment
60
Registered
2020-07-07
Start date
2020-09-17
Completion date
2020-12-31
Last updated
2021-01-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Proinflammatory Cytokines, Skin Conditions

Brief summary

To assess a resveratrol formula on improvement of skin conditions and inflammatory cytokines in blood

Interventions

DIETARY_SUPPLEMENTResveratrol drink

Subjects will consume a bottle of resveratrol drink for two months.

DIETARY_SUPPLEMENTPlacebo drink

Subjects will consume a bottle of placebo drink for two months.

Sponsors

TCI Co., Ltd.
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
20 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Healthy volunteers aged above 20 years old

Exclusion criteria

* Subject who is not willing to participate in this study. * Patients with diseases of the skin, heart, liver, kidney, endocrine and other organs and patients with mental illness (according to medical history). * Subjects who have known cosmetic, drug or food allergies, difficulty in digestive tract absorption or disorder. * Female who is pregnant or nursing or planning to become pregnant during the course of the study. * Received facial laser therapy, chemical peeling or UV overexposure in the past 4 weeks. * Subjects who have large spots (area \>3 square centimeter) or abnormal acne.

Design outcomes

Primary

MeasureTime frameDescription
The change of skin moisture0, 4, and 8 weeksCorneometer® CM825 was utilized to measure skin moisture. Units: arbitrary Corneometer® units 0-120
The change of skin elasticity0, 4, and 8 weeksCutometer® dual MPA 580 was utilized to measure skin elasticity (parameter R2). Units: μm penetration depth into the probe opening, expressed as curves
The change of skin wrinkles0, 4, and 8 weeksVISIA Complexion Analysis System was utilized to measure wrinkles. Units: arbitrary units
The change of skin collagen density0, 4, and 8 weeksDermaLab® USB - 20 MHz High Freq. Ultrasound probe was utilized to scan and analyze skin collagen density. Units: Intensity score
The change of skin texture0, 4, and 8 weeksVISIA Complexion Analysis System was utilized to measure skin texture. Units: arbitrary units
The change of skin pores0, 4, and 8 weeksVISIA Complexion Analysis System was utilized to measure skin pores. Units: arbitrary units
The change of total antioxidant capacity of blood0 and 8 weeksTotal Antioxidant Capacity Assay Kit
The change of TNF-alpha of blood0 and 8 weeksELISA Kit
The change of IL-6 of blood0 and 8 weeksELISA Kit
The change of IL-17 of blood0 and 8 weeksELISA Kit
The change of IL-1β of blood0 and 8 weeksELISA Kit

Countries

Taiwan

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026